RAC2 has been identified as a prognostic biomarker in clear-cell renal carcinoma [51], while PTTG1 has shown potential as a prognostic indicator in hepatocellular carcinoma due to its role in promoting β-catenin stabilization [58]. This evidence concerns the gene RAC2 and clear cell renal carcinoma.